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Polyethylenimine-Enhanced Alumina Nanoscale Adjuvant for Cervical Cancer Vaccine
Naoko Uno1,2, Haiyan Li1, Hong-Ming Hu2, Jun Jiao1
1Department of Physics , Portland State University, 2Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center
Portland, OR, USA
ABSTRACT
Aluminum oxide nanoparticles (Al2O3 NPs) have been shown
to increase the efficiency of cell-mediated immune response.
Specifically, CD8 and CD4 immune response is required for T cell
activation by dendritic cells. These nanoparticles, when
functionalized with peptides and other molecules, can be used as
vaccine in cancer treatment. HPV-induced cervical cancer
expresses E6/E7 antigens. E6/E7 proteins were attached using
surface modification of the Al2O3 NPs; different types of
molecules were tested to see which adhered the highest amount of
protein and produced the strongest cell response. Protein
measurements were done using bicinchoninic acid assay (BCA
assay) and spectrophotometry. CD8 and CD4 immune response
was measured in vivo using flow cytometry. In vitro
measurements of immune response were done using the TC1
tumor line. When coated on the nanoparticles and mixed with
E6/E7 protein, the polymer polyethylenimine (PEI) proved to be
most effective at strengthening the immune response in
vaccinated mice.
Our findings in this study demonstrate the growing importance
of applied physics in the fields of medicine and biology.
Fabrication and characterization of nano-materials are important
for improving vaccine delivery and ensuring effectiveness.
METHODS & MATERIALS
Synthesis and characterization: Al2O3 nanoparticles (40-80
nm) were functionalized via ultra-sonication. Imaging of the PEIcoated Al2O3 NPs was performed on the transmission electron
microscope. The specimen was dried in a vacuum oven on a lacy
carbon grid. The FEI Tecnai F-20 200kV field emission high
resolution TEM was used for imaging. E6/E7 protein attachment
to the NPs was carried out overnight. measurement of protein
attachment was done using the spectrometer Nanodrop’s protein
assay and BCA assay.
T cell activation: Antigen was injected into C57BL/6 mice by
intramuscular injection. One week post vaccination, the spleens
were harvested and re-stimulated with E6/E7, OVA, and antiCD3. After surface staining with PE CD8, FITC CD4, and
intracullelar staining with APC IFNgamma, T cell response was
measured by flow cytometry.
We also measured the capability of the dendritic cells pulsed by
PEI enhanced Alumina NP carrying antigen to activate CFSE
(carboxyfluorescein diacetate succinimidyl ester)-stained naïve
OT-1 T cells when incubated with cancer cell line that responds to
E6/E7.

T CELL IMMUNE PROCESS

CONCLUSION
Using transmission electron microscopy, the
presence of branched polyethylenimine (PEI)
around the alumina NPs could be detected and
imaged.

RESULTS
Modification of Alumina NPs with Polyethylenimine
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Surface modification of Al2O3 NPs with PEI was
accomplished via ultra-sonication. Diagram A is an
illustration of the functionalization. Figure 1a is a
transmission electron microscope (TEM) image of naked
alumina. Figures 1b and 1c show that PEI is coating the
Al2O3 NP. The electron beam from the microscope cause
the polymer to form bubbles. Figure 1c is a high
magnification of the sample, showing the lattice fringes
of the polycrystalline Al2O3.
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PEI-modified Al2O3 NPs most efficiently loaded
proteins. Thus, it demonstrated to be highly
effective in improving antigen delivery by Al2O3
NPs.
Out of the different structures and weights of PEI,
the branched polymer (25kDa) produced the most
CD4 and CD8 response. Higher titrations of the NPs
also produced higher T cell signals.

FUTURE WORK
Improve dispersion- the PEI-enhanced alumina NPs
do not stay dispersed in solution and settles to the
bottom. This makes accurate injection dosage difficult
to determine.
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PEI efficiently enhance alumina nanoscale adjuvancy
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Different molecules were analyzed for their efficiency at protein attachment (Figure 2a). Al2O3
NPs were coated with the polymer styrene maleic anhydride (SMA), PEI, the chemical
aminophenol (AP), aminophenol cross-linked with SPDP (SPDP), and polyvinylpyrrolidone
(PVP). After determining that PEI was the best candidate for improving antigen delivery,
different forms and weights of PEI were tested in vivo. Mice were injected with five different
samples: branched PEI at 25k Daltons (“B25000”) and 800 Da (“B800”), linear PEI at 25k Da
(“L25000”) and 800 Da (“L800”), and E6/E7 (protein only). Flow cytometry determined that
the branched PEI at 25kDa stimulated the most CD8 and CD4 immune response when restimulated with E6/E7 protein (figures 2b and 2c).

Amorphous Al2O3 NPs stay well-dispersed when coated
with PEI. We have done a simple in vitro assay using
frozen DC2.4 and B3Z T cells. These T cells respond to
ovalbumin (OVA), so we attached OVA to the NPs.
CPRG reagent staining and spectrometer absorbancy
reading show the T cell response to DCs pulsed with
different NPs at different titrations of antigen (figure 4).
The size of the amorphous NPs are too small, 15nm, so
we need to find an optimal size so the PEI coating does
not overwhelm the capabilities of the alumina.
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Antigen presenting cells (APCs) such as dendritic cells (DCs)
process and present antigen to naïve T cells via the Major
Histocompatability Complex (MHC). MHCII activates CD4+
helper T cells which activate other immune cells against the
antigen . MHCI activate CD8+ T cells which kill antigen-positive
cancer cells.

Different titrations of PEI-coated Al2O3 NPs were tested in vivo to compare CD4 and CD8
immune response to re-stimulation (figures 3a and 3b). They were also tested to see the
effectiveness of killing TC1 tumor cells (figure 3c). The NPs were compared with Alum, which
is an FDA approved adjuvant.
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